These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1072 related articles for article (PubMed ID: 20129531)

  • 41. Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.
    Rodriguez-Granillo GA; Rosales MA; Baum S; Rennes P; Rodriguez-Pagani C; Curotto V; Fernandez-Pereira C; Llaurado C; Risau G; Degrossi E; Doval HC; Rodriguez AE
    JACC Cardiovasc Imaging; 2009 Sep; 2(9):1072-81. PubMed ID: 19761985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
    Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
    J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study.
    Ali A; Cox D; Dib N; Brodie B; Berman D; Gupta N; Browne K; Iwaoka R; Azrin M; Stapleton D; Setum C; Popma J;
    J Am Coll Cardiol; 2006 Jul; 48(2):244-52. PubMed ID: 16843170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Rasoul S; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Marcel Gosselink AT; Zijlstra F; Suryapranata H; van 't Hof AW;
    Coron Artery Dis; 2009 Sep; 20(6):415-21. PubMed ID: 19641460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.
    Song YB; Hahn JY; Gwon HC; Kim JH; Lee SY; Choe YH; Choi SH; Choi JH; Lee SH
    Clin Cardiol; 2009 Jun; 32(6):321-6. PubMed ID: 19569068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Facilitated primary coronary intervention with abciximab and very low dose of alteplase during off-hours compared with direct primary intervention during regular hours.
    Maioli M; Gallopin M; Leoncini M; Bellandi F; Toso A; Dabizzi RP
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):484-91. PubMed ID: 15973688
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the angiographic myocardial blush grade with delayed-enhanced cardiac magnetic resonance for the assessment of microvascular obstruction in acute myocardial infarctions.
    Vicente J; Mewton N; Croisille P; Staat P; Bonnefoy-Cudraz E; Ovize M; Revel D
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1000-7. PubMed ID: 19626683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
    Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
    Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI Trial (INFUSE-Anterior Myocardial Infarction).
    Guerchicoff A; Brener SJ; Maehara A; Witzenbichler B; Fahy M; Xu K; Gersh BJ; Mehran R; Gibson CM; Stone GW
    JACC Cardiovasc Interv; 2014 Jul; 7(7):733-40. PubMed ID: 25060015
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial.
    Caixeta A; Lansky AJ; Mehran R; Brener SJ; Claessen B; Généreux P; Palmerini T; Witzenbichler B; Guagliumi G; Brodie BR; Dudek D; Fahy M; Dangas GD; Stone GW;
    EuroIntervention; 2013 Jun; 9(2):220-7. PubMed ID: 23518872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
    Pride YB; Giuseffi JL; Mohanavelu S; Harrigan CJ; Manning WJ; Gibson CM; Appelbaum E
    Am J Cardiol; 2010 Sep; 106(5):635-40. PubMed ID: 20723637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction.
    Kitabata H; Imanishi T; Kubo T; Takarada S; Kashiwagi M; Matsumoto H; Tsujioka H; Ikejima H; Arita Y; Okochi K; Kuroi A; Ueno S; Kataiwa H; Tanimoto T; Yamano T; Hirata K; Nakamura N; Tanaka A; Mizukoshi M; Akasaka T
    JACC Cardiovasc Imaging; 2009 Mar; 2(3):263-72. PubMed ID: 19356570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
    Ørn S; Ueland T; Manhenke C; Sandanger Ø; Godang K; Yndestad A; Mollnes TE; Dickstein K; Aukrust P
    J Intern Med; 2012 Sep; 272(3):267-76. PubMed ID: 22243053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial.
    Kim EK; Hahn JY; Song YB; Lee SC; Choi JH; Choi SH; Lee SH; Choe YH; Gwon HC
    Int J Cardiovasc Imaging; 2015 Mar; 31(3):629-37. PubMed ID: 25589306
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence, predictors, and prognostic value of intramyocardial hemorrhage lesions in ST elevation myocardial infarction.
    Amabile N; Jacquier A; Shuhab A; Gaudart J; Bartoli JM; Paganelli F; Moulin G
    Catheter Cardiovasc Interv; 2012 Jun; 79(7):1101-8. PubMed ID: 21805604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognosis after ST-elevation myocardial infarction: a study on cardiac magnetic resonance imaging versus clinical routine.
    de Waha S; Eitel I; Desch S; Fuernau G; Lurz P; Stiermaier T; Blazek S; Schuler G; Thiele H
    Trials; 2014 Jun; 15():249. PubMed ID: 24962156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction.
    Mills JS; Mahaffey KW; Lokhnygina Y; Nicolau JC; Ruzyllo W; Adams PX; Todaro TG; Armstrong PW; Granger CB;
    Coron Artery Dis; 2012 Mar; 23(2):118-25. PubMed ID: 22217457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.